8-K: BioSig Technologies to Merge with Streamex Exchange Corp., Entering Real-World Asset Tokenization

BioSig Technologies plans to merge with Streamex Exchange Corporation in an all-stock transaction, pivoting towards real-world asset tokenization.

Summary

• BioSig Technologies, Inc. has entered into a Letter of Intent (LOI) to merge with Streamex Exchange Corporation.
• The merger aims to create a publicly listed real-world asset tokenization company on the Nasdaq.
• Streamex stockholders will own approximately 19.9% of BioSig's common stock immediately after the merger.
• Streamex stockholders will also receive convertible preferred stock, which, upon conversion, will result in them owning approximately 75% of BioSig's outstanding common stock.
• BioSig's current shareholders will retain the remaining equity.
• The merger is subject to due diligence, definitive documentation, and regulatory approvals.
• BioSig intends to raise at least $5 million USD of equity capital, with up to $10 million USD committed for investment into the combined company, following the merger agreement.
• Anthony Amato will resign as CEO, and Karl Henry McPhie will be his replacement at the time of the Merger.
• The board of directors will consist of six members, with four designated by BioSig and two by Streamex.
• The company will hold a special meeting to approve the issuance of more than 19.9% of common stock upon conversion of the Series X preferred stock.

Sentiment

Score: 6

Explanation: While the merger presents growth opportunities, the significant dilution for existing shareholders tempers the overall positive outlook.

Positives

• The merger provides BioSig with an entry into the high-growth real-world asset tokenization market.
• Streamex brings a fully developed and operational primary issuance and decentralized exchange infrastructure.
• The combined company will be led by seasoned executives from the financial, commodities, and blockchain industries.
• Strategic advisors like Frank Giustra, Mathew August, and Mitchell Williams bring significant expertise and connections.
• The transaction aims to enhance liquidity, accessibility, and efficiency in commodity finance.

Negatives

• Existing BioSig shareholders will experience significant dilution, retaining only approximately 25% of the company's equity after the merger and conversion of preferred stock.
• The merger is subject to various conditions, including due diligence and regulatory approvals, which may not be satisfied.
• Anthony Amato wishes to resign as CEO of the Company and Karl Henry McPhie shall be his replacement at the time of the Merger.
• The company will incur expenses related to the merger, including legal, accounting, and third-party fees.

Risks

• The merger may not be completed if due diligence is unsatisfactory or definitive agreements are not reached.
• Regulatory or listing approvals may be delayed or denied.
• The integration of BioSig and Streamex may present operational and management challenges.
• The company's ability to raise the targeted $5 million USD in equity capital is not guaranteed.
• The success of the real-world asset tokenization platform depends on market adoption and regulatory developments.

Future Outlook

The company anticipates significant growth potential through the merger with Streamex, expanding its market reach and enhancing its capabilities in the real-world asset tokenization space.

Management Comments

• Streamex Co-Founders Henry McPhie and Morgan Lekstrom believe this is the next evolution of commodity and traditional finance.
• BioSig's CEO, Anthony Amato, sees the merger as a transformative opportunity for the company and its shareholders.

Industry Context

The merger reflects a growing trend of traditional companies entering the blockchain and digital asset space, following examples of large financial institutions like BlackRock, Goldman Sachs, and HSBC tokenizing assets.

Comparison to Industry Standards

• The document mentions BlackRock, Goldman Sachs and HSBC as examples of large financial institutions that have already tokenized assets and brought them on chain.
• The document mentions NexGold Mining Corp. (NEXG-TSX) and Premium Resources (PREM-TSX) as comparible companies.
• The document mentions LionsGate Films (LGF-NYSE), Wheaton Precious Metals, (WPM-NYSE), and GoldCorp, acquired by Newmont (NEM) as companies founded by Frank Giustra.

Management Changes

Stakeholder Impact

• Shareholders will experience significant dilution but may benefit from the company's entry into a new market.
• Employees may experience changes in leadership and organizational structure.
• Customers may see new product offerings related to real-world asset tokenization.

Next Steps

• Completion of due diligence by both parties.
• Negotiation and preparation of definitive merger agreements within 30 days.
• Filing a registration statement to raise equity capital.
• Holding a special stockholder meeting to approve the merger and related matters.
• Obtaining regulatory and Nasdaq approvals.

Key Dates

Keywords

merger, Streamex, BioSig, tokenization, commodities, blockchain, Nasdaq, equity, finance, assets